Gufic Biosciences has informed that the Board of Directors of the Company at its meeting held on November 24, 2016, has approved the Scheme of Amalgamation of Gufic Stridden Bio-Pharma with the Company, subject to the necessary approvals.
The above information is a part of company’s filings submitted to BSE.